Patheon was founded in 1974 and is headquartered in Durham, US
Report incorrect company information
Patheon Office Locations
Patheon has an office in Durham
Durham, US (HQ)
300 4815 Emperor Blvd
Report incorrect company information
Patheon Financials and Metrics
Summary Metrics
Founding Date | 1974 |
Patheon is a subsidiary of Thermo Fisher Scientific
Patheon Financials
Patheon's revenue was reported to be $1.02 b in FY, 2013
| USD | FY, 2013 |
|---|---|
Revenue | 1 b |
Cost of goods sold | 774 m |
Gross profit | 249.1 m |
Gross profit Margin, % | 24% |
| USD | FY, 2013 |
|---|---|
Cash | 61.6 m |
Accounts Receivable | 191.3 m |
Inventories | 137.8 m |
Current Assets | 415.7 m |
| USD | FY, 2013 |
|---|---|
Depreciation and Amortization | 48.4 m |
Cash From Operating Activities | 13 m |
Report incorrect company information
Patheon News and Updates
April 13, 2018
Thermo Fisher spotlights its problem-solvers in campaign aimed at pharma clients
Thermo Fisher is showing its real face to pharma clients. Make that faces—those of its employees and the patients they help. In its new campaign, Thermo Fisher Scientific Pharma Services is looking to personalize its end-to-end drug development and delivery services for pharma companies.
February 23, 2018
Empty Capsules Market to Surpass US$ 2.79 Billion Threshold by 2025 Globally
Empty capsules market to surpass US$ 2.79 billion threshold by 2025 globally, with development of capsules integrated with advanced technologies such as extended release Posted via Industry Today. Follow us on Twitter @IndustryToday
September 26, 2017
Pharmaceutical Solid Dosage Contract Manufacturing Market to witness steady increase by 2024
The major factors that are driving the pharmaceutical solid dosage contract manufacturing market include lower and more flexible manufacturing, reduced net costs, streamlined development, and availability of the higher quality product. Posted via Industry Today. Follow us on Twitter @IndustryToday
September 13, 2017
Pharmaceutical Solid Dosage Contract Manufacturing Market: Industry Latest Trends & Global Outlook 2016-2024
The major factors that are driving the pharmaceutical solid dosage contract manufacturing market include lower and more flexible manufacturing, reduced net costs, streamlined development, and availability of the higher quality product. Posted via Industry Today. Follow us on Twitter @IndustryToday
August 14, 2017
Vicarius Pharma lands $21.8 mln
Switzerland-based Vicarius Pharma AG, which provides U.S.-based biopharmaceutical companies a "novel approach" to commercializing assets in European markets, has raised $21.8 million in funding. James Mullen, CEO of Patheon and former CEO of Biogen, was the lead investor.
Report incorrect company information